mph Bangladesh

Molecule Info

Indication & Dosage Topical/Cutaneous
Skin fungal infections
Adult: Apply 1% cream on affected area. Tinea pedis: Apply bid for 7 days.Tinea corporis and tinea cruris: Once daily for 2 wk. Tinea versicolor: Once daily for 2 wk.
Administration May be taken with or without food.
Contraindications Application to eye area.
Special Precautions Avoid occlusive dressings. Avoid contact with mouth, eyes and other mucous membranes. Affected areas should be thoroughly cleansed with soap and dried prior to application. Hands should always be washed after applying cream. Child <12 yr.
Adverse Drug Reactions Mild burning sensation at the site of application.
Pregnancy Category (US FDA) Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Storage Topical/Cutaneous: Store at 5-30°C.
Mechanism of Action Butenafine, a benzylamine antifungal, inhibits the enzyme squalene monooxygenase thus decreasing sterol biosynthesis.
ATC Classification D01AE23 - butenafine ; Belongs to the class of other antifungals for topical use. Used in the treatment of fungal infection.

Please consult detailed drug interactions before prescribing. 

Brand/Product Info

Total Products : 2  
Brand Name Manufacturer/Marketer Composition Dosage Form Pack Size & Price
BUTEFIN 1% Square Pharmaceuticals Ltd. Butenafine hydrochloride 1% Cream 10 gm: 40.13 MRP
TENAFIN Beximco Pharmaceuticals Ltd Butenafine Hydrochloride INN 10mg/gm Cream 1's: 50.00 MRP
Simple Breath Test Might Diagnose Heart Failure An experimental breath test, designed to quickly identify patients suffering from heart failure simply by analyzing the contents of a...
Osteoporosis drug stops Breast cancer growth   News & Events News & Events     HIGHLIGHTS Osteoporosis drug stops growth of breast cancer...
Generic drug safety info loophole FDA plans to close generic drug safety info loophole The US Food and Drug Administration has announced plans to speed up the dissemination of...
Large trials unpublished   News & Events News & Events   HIGHLIGHTS Almost 1 in 3 of large clinical trials unpublished after...
TB activists boo Indian minister News & Events News & Events   HIGHLIGHTS TB activists at world conference boo Indian minister off...
Key bone marrow protein identified News & Events News & Events   HIGHLIGHTS Key bone marrow protein identified as potential new leukemia...